Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same

摘要

NZ 599061 The disclosure relates to a pharmaceutical composition for the treatment of cardiovascular disease selected from hypertriglyceridemia, hypercholesterolemia, mixed dyslipidemia, coronary heart disease, vascular disease, stroke, atherosclerosis, arrhythmia, hypertension, and myocardial infarction, wherein the composition comprises: (a) a hydroxy-derivative of a statin or pharmaceutically acceptable salt thereof, wherein the hydroxy-derivative of a statin or pharmaceutically acceptable salt thereof is selected from o-hydroxy atorvastatin, p-hydroxy atorvastatin, p-hydroxy atorvastatin calcium, p-hydroxy atorvastatin disodium, o-hydroxy atorvastatin calcium, o-hydroxy atorvastatin lactone, ohydroxy atorvastatin-d5 calcium, o-hydroxy atorvastatin-d5 disodium, o-hydroxy atorvastatin-d5 lactone, 2-hydroxy atorvastatin bisodium, p-hydroxy atorvastatin lactone, p-hydroxy atorvastatin-d5 calcium, p-hydroxy atorvastatin-d5 lactone, and 4-hydroxy atorvastatin bisodium; and (b) an oil comprising an omega-3 fatty acid which comprises ethyl eicosapentaenoate and ethyl docosahexaenoate.